Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma

In classical Hodgkin lymphoma, circulating clonotypic malignant cells express CD20, which potentially explains the observed activity of rituximab. This multicenter phase 2 study investigated the combination of rituximab-ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) for stage II-IV untreate...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Kasamon, Yvette L., Jacene, Heather A., Gocke, Christopher D., Swinnen, Lode J., Gladstone, Douglas E., Perkins, Brandy, Link, Brian K., Popplewell, Leslie L., Habermann, Thomas M., Herman, Joseph M., Matsui, William H., Jones, Richard J., Ambinder, Richard F.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2012
Fag:
Clinical Trials and Observations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359734/
https://ncbi.nlm.nih.gov/pubmed/22343727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-01-402792
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker